The Effect of AI-Assisted Expressive Writing on Anxiety, Emotional Distress, and Quality of Life Among Patients Receiving Chemotherapy: A Mixed-Methods Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Change in Anxiety and Emotional Distress Scores
研究概览
简要总结
This study aims to evaluate the effect of an AI-assisted expressive writing intervention on anxiety, emotional distress, and quality of life among patients receiving chemotherapy. A mixed-methods, interventional research design will be employed. Participants will be assigned to either a study group receiving the AI-assisted expressive writing program in addition to routine care or a control group receiving routine care only. Quantitative data will be collected using the Depression Anxiety Stress Scale-21 (DASS-21) and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30). Qualitative data will be obtained through semi-structured interviews to explore participants' experiences with the intervention. The findings are expected to provide evidence regarding the effectiveness of AI-assisted expressive writing as a supportive strategy for improving psychological well-being and quality of life among patients undergoing chemotherapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients aged 18 years and above.
- •Diagnosed with any type of cancer and currently receiving chemotherapy treatment.
- •Able to read and write Arabic.
- •Able to communicate and express thoughts and feelings.
- •Have access to a smartphone, tablet, or computer with internet connectivity.
- •Willing to participate in the study and provide informed consent.
排除标准
- •Diagnosed with severe psychiatric disorders (e.g., psychosis or schizophrenia).
- •Having cognitive impairment that interferes with understanding or communication.
- •Currently receiving structured psychological therapy during the study period.
- •Unable to complete the study questionnaires or intervention sessions.
- •Refusal to participate or withdrawal from the study at any time.
结局指标
主要结局
Change in Anxiety and Emotional Distress Scores
时间窗: Baseline (Day 1) and Week 4 after intervention
Anxiety and emotional distress will be measured using the Depression Anxiety Stress Scale-21 (DASS-21). Changes in participants' scores will be assessed before and after the intervention. Higher scores indicate greater levels of psychological distress.
Change in Quality of Life Scores
时间窗: Baseline (Day 1) and Week 4 after intervention
Quality of life will be assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30). Changes in quality-of-life scores will be evaluated before and after the intervention.
次要结局
- Participants' Experiences with AI-Assisted Expressive Writing(Week 4 after intervention)
研究者
Mohamed Fakhry Ahmed Salem
Lecturer of Medical-Surgical Nursing
Alexandria University